| CONTRIBUTORS TO VOLUME 282 |
|
ix | (4) |
| PREFACE |
|
xiii | (2) |
| VOLUMES IN SERIES |
|
xv | |
| Section I. Vitamin A |
|
3 | (154) |
|
1. Generation and Characterization of Cellular Retinoic Acid-Binding Proteins from Escherichia coli Expression Systems |
|
|
3 | (10) |
|
|
|
|
|
|
|
|
|
|
|
2. Generating and Characterizing Retinoid Receptors from Escherichia coli and Insect Cell Expression Systems |
|
|
13 | (12) |
|
|
|
|
|
|
|
|
|
|
|
3. Expression and Characterization of Retinoid Receptors in Yeast |
|
|
25 | (8) |
|
|
|
|
|
|
|
|
|
|
|
4. Use of in Situ Hybridization Techniques to Study Embryonic Expression of Retinoid Receptors and Binding Proteins |
|
|
33 | (15) |
|
|
|
|
|
|
|
|
|
|
|
5. Use of Quantitative Polymerase Chain Reaction to Study Retinoid Receptor Expression |
|
|
48 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6. Use of Quantitative Polymerase Chain Reaction to Study Cellular Retinoic Acid-Binding Protein-II mRNA Expression in Human Skin |
|
|
64 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7. Use of Transgenic Mice to Study Activation of Retinoic Acid-Responsive Promoters |
|
|
77 | (8) |
|
|
|
|
|
|
|
|
|
|
|
8. Use of Transgenic Mice to Eliminate Retinoic Acid Receptor Function in Specific Tissues |
|
|
85 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. Use of Reporter Cells to Study Endogenous Retinoid Sources in Embryonic Tissues |
|
|
98 | (10) |
|
|
|
|
|
|
10. Preparation of Radiolabeled 9-cis- and all-trans-Retinoids |
|
|
108 | (9) |
|
|
|
|
|
|
|
|
|
|
|
11. Identification and Quantification of Retinoic Acid and Other Metabolites from Beta-Carotene Excentric Cleavage in Human Intestine in Vitro and Ferret Intestine in Vivo |
|
|
117 | (13) |
|
|
|
|
|
|
|
|
|
|
|
12. Assessing Metabolism of Beta-[(13)C]Carotene Using High-Precision Isotope Ratio Mass Spectrometry |
|
|
130 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13. Atmospheric Pressure Chemical Ionization and Electron Capture Negative Chemical Ionization Mass Spectrometry in Studying Beta-Carotene Conversion to Retinol in Humans |
|
|
140 | (17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Section II. Vitamin D |
|
157 | (90) |
|
14. Synthesis of [3XXX-(3)H]Vitamin D(3) and 1XXX,25-Dihydroxy[1Beta-(3)H]Vitamin D(3) |
|
|
157 | (7) |
|
|
|
|
|
|
|
|
|
|
|
15. Assay of 1,25-Dihydroxyvitamin D(3) from Serum Samples: Use of Receptor-Binding or Enzyme-Coupled Reporter Analysis |
|
|
164 | (10) |
|
|
|
|
|
|
|
|
|
|
|
16. Quantitation of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D by Radioimmunoassay Using Radioiodinated Tracers |
|
|
174 | (12) |
|
|
|
|
|
|
17. Assay of Vitamin D Derivatives and Purification of Vitamin D Hydroxylases |
|
|
186 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18. Assay of 25-Hydroxyvitamin D 1XXX-Hydroxylase and 24-Hydroxylase |
|
|
200 | (13) |
|
|
|
|
|
|
|
|
|
|
|
19. Molecular Cloning of Vitamin D(3) Hydroxylases |
|
|
213 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20. Role of 1XXX,25-Dihydroxyvitamin D(3) in Osteoclast Differentiation and Function |
|
|
223 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21. Assay of Direct Effect of 1,25-Dihydroxyvitamin D(3) on Calcium Ion Influx into Cultured Osteoblasts |
|
|
236 | (11) |
|
|
|
|
|
|
|
|
|
|
| Section III. Vitamin E |
|
247 | (66) |
|
22. Vitamin E Status and Immune Function |
|
|
247 | (17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23. Inhibition of Platelet Adhesion as Functional Test for Vitamin E Status |
|
|
264 | (7) |
|
|
|
|
|
|
24. Inhibition of Plasma Cholesterol Ester Hydroperoxide and Phosphatidylcholine Hydroperoxide Formation as Measures of Antioxidant Status |
|
|
271 | (7) |
|
|
|
|
|
|
|
|
|
|
|
25. XXX-Tocopherol-Binding Proteins: Purification and Characterization |
|
|
278 | (19) |
|
|
|
|
|
|
26. XXX-Carboxyethyl-6-Hydroxychroman as Urinary Metabolite of Vitamin E |
|
|
297 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Section IV. Vitamin K |
|
313 | (154) |
|
27. Purification of Vitamin K-Dependent Carboxylase from Cultured Cells |
|
|
313 | (20) |
|
|
|
|
|
|
|
|
|
|
|
28. Purification of Native Bovine Carboxylase and Expression and Purification of Recombinant Bovine Carboxylase |
|
|
333 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29. Purification of XXX-Glutamyl Carboxylase from Bovine Liver |
|
|
346 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30. Assay of Vitamin K-Dependent Carboxylase Activity in Hepatic and Extrahepatic Tissues |
|
|
358 | (11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31. Expression of Human Anticoagulation Protein C and XXX-Carboxyglutamic Acid Mutants in Mammalian Cell Cultures |
|
|
369 | (15) |
|
|
|
|
|
|
|
|
|
|
|
32. Determination of Site-Specific XXX-Carboxyglutamic Acid Formation by Vitamin K-Dependent Carboxylase Utilizing De-XXX-carboxy Bone Gla Protein as Substrate |
|
|
384 | (11) |
|
|
|
|
|
|
|
|
|
|
|
33. Purification of Warfarin-Sensitive Vitamin K Epoxide Reductase |
|
|
395 | (13) |
|
|
|
|
|
|
|
|
|
|
|
34. Determination of Vitamin K Compounds in Plasma or Serum by High-Performance Liquid Chromatography Using Postcolumn Chemical Reduction and Fluorimetric Detection |
|
|
408 | (13) |
|
|
|
|
|
|
|
|
|
|
|
35. Assay of Phylloquinone in Plasma by High-Performance Liquid Chromatography with Electrochemical Detection |
|
|
421 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36. Assay of Menaquinones in Plasma Utilizing Dual-Electrode Electrochemical Detection |
|
|
434 | (4) |
|
|
|
|
|
|
37. Assay of Phylloquinone and Menaquinones in Human Liver |
|
|
438 | (8) |
|
|
|
|
|
|
38. Determination of Phylloquinone in Foods by High-Performance Liquid Chromatography |
|
|
446 | (11) |
|
|
|
|
|
|
|
|
|
|
|
39. Assay of Menaquinones in Bacterial Cultures, Stool Samples, and Intestinal Contents |
|
|
457 | (10) |
|
|
|
|
|
| AUTHOR INDEX |
|
467 | (24) |
| SUBJECT INDEX |
|
491 | |
Other versions by this Author